Drug Shortage Report for TEVA-PANTOPRAZOLE MAGNESIUM
Report ID | 59708 |
Drug Identification Number | 02440628 |
Brand name | TEVA-PANTOPRAZOLE MAGNESIUM |
Common or Proper name | PANTOPRAZOLE MAGNESIUM |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | PANTOPRAZOLE |
Strength(s) | 40MG |
Dosage form(s) | TABLET (DELAYED-RELEASE) |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2018-07-15 |
Estimated end date | 2019-03-30 |
Actual end date | 2019-03-30 |
Shortage status | Resolved |
Updated date | 2019-04-11 |
Company comments | Product being allocated monthly but cannot support additional demand. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2019-04-11 | French | Compare |
v7 | 2019-04-11 | English | Compare |
v6 | 2019-03-12 | French | Compare |
v5 | 2019-03-12 | English | Compare |
v4 | 2019-01-03 | French | Compare |
v3 | 2019-01-03 | English | Compare |
v2 | 2018-08-31 | French | Compare |
v1 | 2018-08-31 | English | Compare |
Showing 1 to 8 of 8